Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine and vincristine.

E Stege; J.M. Kros; Hendrik Bruin; RH Enting; null Heuvel; LHJ (Leendert) Looijenga; Karin van der Rijt; Peter Sillevis Smitt; Martin van den Bent

doi:10.1002/cncr.20828

Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine and vincristine.

E Stege, J.M. Kros, Hendrik Bruin, RH Enting, Heuvel, LHJ (Leendert) Looijenga, Karin van der Rijt, Peter Sillevis Smitt, Martin van den Bent

Research output: Contribution to journal › Article › Academic › peer-review

120 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	802-809
Number of pages	8
Journal	Cancer
Volume	4
DOIs	https://doi.org/10.1002/cncr.20828
Publication status	Published - 2005

Research programs

EMC MM-03-24-01
EMC MM-03-44-06
EMC MM-03-86-08
EMC NIHES-03-30-01
EMC OR-01-86-13

Access to Document

10.1002/cncr.20828

http://hdl.handle.net/1765/70385

Cite this

@article{2096c5a2ad3f46eeb2722331d86ebf38,

title = "Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine and vincristine.",

author = "E Stege and J.M. Kros and Hendrik Bruin and RH Enting and Heuvel and Looijenga, {LHJ (Leendert)} and {van der Rijt}, Karin and {Sillevis Smitt}, Peter and {van den Bent}, Martin",

year = "2005",

doi = "10.1002/cncr.20828",

language = "Undefined/Unknown",

volume = "4",

pages = "802--809",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine and vincristine.

AU - Stege, E

AU - Kros, J.M.

AU - Bruin, Hendrik

AU - Enting, RH

AU - Heuvel, null

AU - Looijenga, LHJ (Leendert)

AU - van der Rijt, Karin

AU - Sillevis Smitt, Peter

AU - van den Bent, Martin

PY - 2005

Y1 - 2005

U2 - 10.1002/cncr.20828

DO - 10.1002/cncr.20828

M3 - Article

C2 - 15637687

SN - 0008-543X

VL - 4

SP - 802

EP - 809

JO - Cancer

JF - Cancer

ER -